Riluzole prescribing, uptake and treatment discontinuation in people with amyotrophic lateral sclerosis in Scotland

Ítems similars

• The Prevalence and Management of Saliva Problems in Motor Neuron Disease: A 4-Year Analysis of the Scottish Motor Neuron Disease Register
  per: Pearson, Iona, et al.
  Publicat: (2020)
• Prospective observational cohort study of factors influencing trial participation in people with motor neuron disease (FIT-participation-MND): a protocol
  per: Beswick, Emily, et al.
  Publicat: (2021)
• The immediate impact of the COVID-19 pandemic on motor neuron disease services and mortality in Scotland
  per: Glasmacher, Stella A., et al.
  Publicat: (2020)
• Correction to: The immediate impact of the COVID‑19 pandemic on motor neuron disease services and mortality in Scotland
  per: Glasmacher, Stella A., et al.
  Publicat: (2020)
• Cerebrospinal fluid cytotoxicity in amyotrophic lateral sclerosis: a systematic review of in vitro studies
  per: Ng Kee Kwong, Koy Chong, et al.
  Publicat: (2020)